Call for Paper - Upcoming Issues

Evaluation of Aorto-Bifemoral Bypass in Treatment of Chronic Obstructive Aorto-Iliac Disease

International Journal of Medical Science
© 2024 by SSRG - IJMS Journal
Volume 11 Issue 3
Year of Publication : 2024
Authors : Moustafa Emad Aldeen Nezha, Ghanem Ahmad, Ali Kafa
10.14445/23939117/IJMS-V11I3P104
pdf
How to Cite?

Moustafa Emad Aldeen Nezha, Ghanem Ahmad, Ali Kafa, "Evaluation of Aorto-Bifemoral Bypass in Treatment of Chronic Obstructive Aorto-Iliac Disease," SSRG International Journal of Medical Science, vol. 11,  no. 3, pp. 16-22, 2024. Crossref, https://doi.org/10.14445/23939117/IJMS-V11I3P104

Abstract:

Chronic Aortoiliac Occlusive Disease (AIOD) is a multifactorial vascular disorder, and management of it is considered a challenge for vascular surgeons. Objective: The study aims to assess outcomes after aortofemoral bypass. Patients and Methods: This is an observational descriptive study of patients with proven diagnosis of AIOD who underwent aortofemoral bypass at the Department of Vascular Surgery- Tishreen University Hospital in Lattakia-Syria from January 2021 through January 2023. Results: The population of patients is predominantly males (82.9%), with a mean age of 53.29±5.3 years. The high percentage of patients suffering from various risk factors for AIOD, in which hypertension represents the most frequent one (48.6%), with the presence of a history of smoking in 23 cases (65.7%). The rate of clinical improvement of intermittent claudication is 88.6% at 1 month after surgery, which decreased to 80% at 12 months. There is a significant correlation between the status of peripheral vessels and the degree of improvement, in which the rate of clinical improvement is 89.3% at 12 months after surgery in patients with good blood flow versus 42.9% in cases with poor blood flow, p<0.05. Duration of hospitalization is longer than 7 days in 71.4% of patients, with the incidence of postoperative mortality is 5.7% within 30 days of surgery. Wound infection (11.4%) and sexual dysfunction (11.4%) represent the most frequent early complications, whereas thrombosis of graft (11.4%) represents the most frequent late complication. Conclusion: The current study reveals the beneficial effects of aortofemoral bypass on morbidity of AIOD patients' management regarding patency and improvement of clinical symptoms.

Keywords:

Aortofemoral, Aortoiliac Occlusive Disease (AIOD), Bypass, Outcome, Syria.

References:

[1] Mark A. Creager et al., “2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS Key Data Elements and Definitions for Peripheral Atherosclerotic Vascular Disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Peripheral Atherosclerotic Vascular Disease),” Journal of the American College of Cardiology, vol. 125, no. 2, pp. 395-467, 2012.
[CrossRef] [Google Scholar] [Publisher Link]
[2] Alan T. Hirsch et al., “Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care,” JAMA, vol. 285, no. 11, pp. 1317-1324, 2001.
[CrossRef] [Google Scholar] [Publisher Link]
[3] Luis H. Eraso et al., “Peripheral Arterial Disease, Prevalence and Cumulative Risk Factor Profile Analysis,” European Journal of Preventive Cardiology, vol. 21, no. 6, pp. 704-711, 2014.
[CrossRef] [Google Scholar] [Publisher Link]
[4] Jeffrey W. Olin, and Brett A. Sealove, “Peripheral Artery Disease: Current Insights into the Disease and its Diagnosis and Management,” Mayo Clinic Proceedings, vol. 85, no. 7, pp. 678-692, 2010.
[CrossRef] [Google Scholar] [Publisher Link]
[5] Candace Wooten et al., “Anatomical Significance in Aortoiliac Occlusive Disease,” Clinical Anatomy, vol. 27, no. 8, pp. 1264-1274, 2014.
[CrossRef] [Google Scholar] [Publisher Link]
[6] Michael Frederick, John Newman, and Jeffrey Kohlwes, “Leriche Syndrome,” Journal of General Internal Medicine, vol. 25, no. 10, pp. 1102-1104, 2010.
[CrossRef] [Google Scholar] [Publisher Link]
[7] Marie D. Gerhard-Herman et al., “2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines,” Journal of the American College of Cardiology, vol. 69, no. 11, pp. e71-e126, 2017.
[Google Scholar] [Publisher Link]
[8] Michal Tendera et al., “ESC Guidelines on the Diagnosis and Treatment of Peripheral Artery Diseases: Document Covering Atherosclerotic Disease of Extracranial Carotid and Vertebral, Mesenteric, Renal, Upper and Lower Extremity Arteries: The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC),” European Heart Journal, vol. 32, no. 22, pp. 2851-2906, 2011.
[CrossRef] [Google Scholar] [Publisher Link]
[9] Navneet Narula et al., “Pathology of Peripheral Artery Disease in Patients with Critical Limb Ischemia,” Journal of the American College of Cardiology, vol. 72, no. 18, pp. 2152-2163, 2018.
[Google Scholar] [Publisher Link]
[10] Victor Aboyands et al., “The General Prognosis of Patients with Peripheral Arterial Disease Differs According to the Disease Localization,” Journal of the American College of Cardiology, vol. 55, no. 9, pp. 898-903, 2010.
[Google Scholar] [Publisher Link]
[11] Asad J. Choudhry, and Palma M. Shaw, “Endovascular Aorto-iliac Reconstruction vs. Aortobifemoral Bypass as First Choice for a Durable Revascularization for Aorto-iliac Occlusive Disease,” Vascular and Endovascular Surgery, vol. 57, no. 1, pp. 88-92, 2023.
[CrossRef] [Google Scholar] [Publisher Link]
[12] T.E. Madiba, M. Mars, and J.V. Robbs, “Choosing the Proximal Anastomosis in Aortobifemoral Bypass,” British Journal of Surgery, vol. 84, no. 10, pp. 1416-1418, 1997.
[CrossRef] [Google Scholar] [Publisher Link]
[13] Arsalan Wafi et al., “Contemporary Approaches for the Management of Aorto-iliac Occlusive Disease,” The Journal of Cardiovascular Surgery, vol. 64, no. 4, pp. 351-360, 2023.
[CrossRef] [Google Scholar] [Publisher Link]
[14] Arun Kumar Haridas, and Bharathi Shridhar Bhat, “Classical Open Aorto-bi-femoral Grafting is a Gold Standard Technique in Aorto-iliac Occlusive Disease; The Technique of Double Layered Reinforcing Aorto-graft Proximal Anastomosis with Anterior Augmentation Patchplasty and Its Advantages,” Journal of Vascular Diseases Treatment, vol. 2, no. 2, pp. 7-13, 2018.
[Google Scholar] [Publisher Link]
[15] A. Wressnegger, C. Kinstner, and M. Funovics, “Treatment of the Aorto-Iliac Segment in Complex Lower Extremity Arterial Occlusive Disease,” The Journal of Cardiovascular Surgery, vol. 56, no. 1, pp. 73-79, 2014.
[Google Scholar] [Publisher Link]
[16] Gaurav Sharma et al., “Thirty Year Trends in Aortofemoral Bypass for Aortoiliac Occlusive Disease,” Journal of Vascular Surgery, vol. 68, no. 6, pp. 1796-1804, 2018.
[CrossRef] [Google Scholar] [Publisher Link]
[17] Lazar Davidovic et al., “Aortobifemoral Grafting: Factors Influencing Long-term Results,” Vascular, vol. 12, no. 3, pp. 171-178, 2004.
[CrossRef] [Google Scholar] [Publisher Link]
[18] Sahaj S. Shah et al., “Outcomes of Aortobifemoral Bypass Based on Configuration of the Proximal Anastomosis,” Annals of Vascular Surgery, vol. 97, pp. 66-73, 2023.
[CrossRef] [Google Scholar] [Publisher Link]
[19] Steven R. Bailey et al., “ACC/AHA/SCAI/SIR/SVM 2018 Appropriate Use Criteria for Peripheral Artery Intervention: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Heart Association, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, and Society for Vascular Medicine,” Journal of the American College of Cardiology, vol. 73, no. 2, pp. 214-237, 2019.
[Google Scholar] [Publisher Link]
[20] Gwan-Chul Lee et al., “Ten Years Outcome after Bypass Surgery in Aortoiliac Occlusive Disease,” Journal of the Korean Surgical Society, vol. 82, no. 6, pp. 365-369, 2012.
[CrossRef] [Google Scholar] [Publisher Link]
[21] Y. Kalko et al., “Comparison of Transperitoneal and Retroperitoneal Approaches in Abdominal Aortic Surgery,” Acta Chirurgica Belgica, vol. 108, no. 5, pp. 557-562, 2008.
[CrossRef] [Google Scholar] [Publisher Link]
[22] Indrani Sen, Edwin Stephen, and Sunil Agarwal, “Clinical Profile of Aortoiliac Occlusive Disease and Outcomes of Aortobifemoral Bypass in India,” Journal of Vascular Surgery, vol. 57, no. 2, pp. 20s-25s, 2013.
[CrossRef] [Google Scholar] [Publisher Link]
[23] A.V. Ozcan, B. Emrecan, and I. Gokcin, “Aortobifemoral Bypass via Paramedian Incision and Reroperitoneal Approach for Aortoiliac Occlusive Disease,” Acta Chirurgica Belgica, vol. 113, no. 3, pp. 182-186, 2013.
[CrossRef] [Google Scholar] [Publisher Link]
[24] Kim Bredahl et al., “Mortality and Complications after Aortic Bifurcated Bypass Procedures for Chronic Aortoiliac Occlusive Disease,” Journal of Vascular Surgery, vol. 62, no.1, pp.75-82, 2015.
[CrossRef] [Google Scholar] [Publisher Link]
[25] Abel Lianzauk Thangawng, “Surgical Management of Iliac Occlusive Disease (Technique and Complications),” ME Thesis, Faculty of Medicine, Tishreen University, Lattakia, Syria, 2007.